Type
. Anti-neural antibodies in leprosy sera: further characterization of the antigens. Journal of neuroimmunology. 1989;21(2-3):125-35.
Type
. CD1-positive epidermal Langerhans cells in skin reactions to autologous peripheral-blood-derived mononuclear cells in leprosy patients. International archives of allergy and applied immunology. 1989;89(1):38-42.
Type
. Changes in nerves and neuropeptides in skin from 100 leprosy patients investigated by immunocytochemistry. The Journal of pathology. 1989;157(1):15-26.
Type
. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1988;56(4):537-45.
Type
. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science (New York, N.Y.). 1988;242(4876):259-61.
Type
. Epidermal changes in reactional leprosy: keratinocyte Ia expression as an indicator of cell-mediated immune responses. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1988;56(3):401-7.
Type
. A passive hemagglutination test for leprosy using a synthetic disaccharide antigen. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1988;56(2):255-8.
Type
. A patient with lepromatous leprosy and anticytoskeletal antibodies. Journal of the American Academy of Dermatology. 1988;18(5 Pt 2):1179-84.
Type
. Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1988;56(1):1-9.
Type
. Defective intralesional interferon-gamma activity in patients with lepromatous leprosy. Clinical and experimental immunology [Internet]. 1988;71(2):235-40. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1541447/pdf/clinexpimmunol00101-0031.pdf